JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CVSA
3001
Covista Inc
CVSA
$4.31B
| $1.51M | ﹤0.01% |
56,395
-7,444
| -12% | -$237K |
2013 Q2
27 quarters
|
|
3002
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.64B
| $1.51M | ﹤0.01% |
27,358
| – | – |
2017 Q3
10 quarters
|
|
|
SWCH
3003
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $1.51M | ﹤0.01% |
104,653
+100,417
| +2,371% | +$1.53M |
2017 Q4
9 quarters
|
|
3004
Insperity
NSP
$1.77B
| $1.51M | ﹤0.01% |
40,420
-42,972
| -52% | -$3.05M |
2014 Q4
21 quarters
|
|
3005
KVH Industries
KVHI
$124M
| $1.5M | ﹤0.01% |
159,252
+145,512
| +1,059% | +$1.49M |
2017 Q4
9 quarters
|
|
3006
PUT
Papa John's
PZZA
$645M
| $1.5M | ﹤0.01% |
28,100
-210,000
| -88% | -$12.6M |
2019 Q2
3 quarters
|
|
|
3007
Papa John's
PZZA
$645M
| $1.5M | ﹤0.01% |
28,051
-2,811
| -9% | -$169K |
2013 Q2
27 quarters
|
|
3008
News Corp Class B
NWS
$17B
| $1.5M | ﹤0.01% |
166,436
+72,645
| +77% | +$935K |
2015 Q3
18 quarters
|
|
|
RRD
3009
DELISTED
RR Donnelley & Sons Co.
RRD
| $1.5M | ﹤0.01% |
1,559,673
+235,639
| +18% | +$570K |
2016 Q4
13 quarters
|
|
|
JCAP
3010
DELISTED
Jernigan Capital, Inc.
JCAP
| $1.49M | ﹤0.01% |
136,312
+8,172
| +6% | +$144K |
2016 Q4
13 quarters
|
|
3011
iShares California Muni Bond ETF
CMF
$4.8B
| $1.49M | ﹤0.01% |
24,628
-550
| -2% | -$33.7K |
2014 Q3
22 quarters
|
|
|
AIMT
3012
DELISTED
Aimmune Therapeutics
AIMT
| $1.49M | ﹤0.01% |
103,289
-15,411
| -13% | -$394K |
2016 Q1
16 quarters
|
|
3013
Dorchester Minerals
DMLP
$1.43B
| $1.49M | ﹤0.01% |
159,836
-12,687
| -7% | -$195K |
2013 Q2
27 quarters
|
|
3014
Invesco Large Cap Growth ETF
PWB
$2.8B
| $1.49M | ﹤0.01% |
33,981
-4,724
| -12% | -$235K |
2016 Q1
16 quarters
|
|
|
CHPMU
3015
DELISTED
CHP Merger Corp. Unit
CHPMU
| $1.49M | ﹤0.01% |
+150,179
| New | +$1.54M |
2020 Q1
0 quarters
|
|
|
BAND
3016
Bandwidth Inc
BAND
$1.93B
| $1.49M | ﹤0.01% |
22,072
+16,852
| +323% | +$1.15M |
2018 Q2
7 quarters
|
|
3017
Blue Bird Corp
BLBD
$1.79B
| $1.48M | ﹤0.01% |
135,554
+21,323
| +19% | +$388K |
2017 Q4
9 quarters
|
|
3018
Utah Medical Products
UTMD
$234M
| $1.48M | ﹤0.01% |
15,738
+12,416
| +374% | +$1.15M |
2015 Q3
18 quarters
|
|
3019
Viasat
VSAT
$10.2B
| $1.48M | ﹤0.01% |
41,207
-9,803
| -19% | -$566K |
2016 Q4
13 quarters
|
|
|
TPTX
3020
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.48M | ﹤0.01% |
33,118
+11,910
| +56% | +$633K |
2019 Q2
3 quarters
|
|
3021
Frontdoor
FTDR
$5.43B
| $1.48M | ﹤0.01% |
42,508
+215
| +0.5% | +$9.15K |
2018 Q4
5 quarters
|
|
|
GDP
3022
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $1.48M | ﹤0.01% |
346,615
-55,772
| -14% | -$345K |
2017 Q2
11 quarters
|
|
3023
State Street SPDR S&P Semiconductor ETF
XSD
$3.31B
| $1.47M | ﹤0.01% |
17,554
-514
| -3% | -$50.8K |
2015 Q1
20 quarters
|
|
3024
Upland Software
UPLD
$11.1M
| $1.47M | ﹤0.01% |
5,491
+847
| +18% | +$306K |
2017 Q2
11 quarters
|
|
3025
York Water
YORW
$500M
| $1.47M | ﹤0.01% |
33,874
+11,674
| +53% | +$530K |
2015 Q4
17 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.